June 26, 2020 / 10:09 PM / 6 days ago

BRIEF-Galectin Therapeutics Says On June 22, Co And Covance Entered Into A Second Work Order Pursuant To The MSA

June 26 (Reuters) - Galectin Therapeutics Inc:

* GALECTIN THERAPEUTICS - ON JUNE 22, CO AND COVANCE ENTERED INTO A SECOND WORK ORDER PURSUANT TO THE MSA

* GALECTIN THERAPEUTICS - PURSUANT TO THE SECOND WORK ORDER, COVANCE AGREES TO PROVIDE SERVICES TO CO IN CONNECTION WITH ITS NASH-RX TRIAL

* GALECTIN - COVANCE SERVICES TO CO IN CONNECTION WITH NASH-RX TRIAL, FOR FEES OF ABOUT $60.0 MILLION FOR PHASE 2B & ABOUT $41.3 MILLION FOR PHASE 3 PORTION Source text: [bit.ly/31xo4Sv] Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below